PBP 2a mutations producing very-high-level resistance to beta-lactams.
about
Carbapenems: past, present, and futureQuantitative proteomic view associated with resistance to clinically important antibiotics in Gram-positive bacteria: a systematic reviewHow allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological functionDisruption of Allosteric Response as an Unprecedented Mechanism of Resistance to AntibioticsTranscriptional profiling of XdrA, a new regulator of spa transcription in Staphylococcus aureusStaphylococcus aureus CcpA affects virulence determinant production and antibiotic resistance.Missense mutations in PBP2A Affecting ceftaroline susceptibility detected in epidemic hospital-acquired methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in Western Switzerland archived since 1998In vivo synergism of ceftobiprole and vancomycin against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.The σB-dependent yabJ-spoVG operon is involved in the regulation of extracellular nuclease, lipase, and protease expression in Staphylococcus aureusPre-Use Susceptibility to Ceftaroline in Clinical Staphylococcus aureus Isolates from Germany: Is There a Non-Susceptible Pool to be Selected?Cephalosporins in clinical development.Whole-genome sequencing reveals a link between β-lactam resistance and synthetases of the alarmone (p)ppGpp in Staphylococcus aureusFunctional characterization of the sigmaB-dependent yabJ-spoVG operon in Staphylococcus aureus: role in methicillin and glycopeptide resistance.Ceftobiprole: first cephalosporin with activity against methicillin-resistant Staphylococcus aureus.Role of the mecA gene in oxacillin resistance in a Staphylococcus aureus clinical strain with a pvl-positive ST59 genetic background.Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus.In vitro selection and characterization of ceftobiprole-resistant methicillin-resistant Staphylococcus aureus.Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.The mecA homolog mecC confers resistance against β-lactams in Staphylococcus aureus irrespective of the genetic strain background.Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.Novel polymorphisms in mec genes and a new mec complex type in methicillin-resistant Staphylococcus aureus isolates obtained in rural Wisconsin.Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assays.Modulation of mecA Gene Expression by Essential Oil from Salvia sclarea and Synergism with Oxacillin in Methicillin Resistant Staphylococcus epidermidis Carrying Different Types of Staphylococcal Chromosomal Cassette mec.Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria.Mechanistic basis for the action of new cephalosporin antibiotics effective against methicillin- and vancomycin-resistant Staphylococcus aureus.Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.The basis for resistance to beta-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus.
P2860
Q24634999-EB7A6625-45E5-4A9D-934E-6156D7243C17Q26796165-C34318C2-EBD1-488F-9F26-2CCCDC384015Q27680124-18A24E75-387D-46BD-A421-85A85B9F13B8Q27684435-893CDB46-0D60-4D94-A28A-35DE477A430BQ34150867-E65FCA4C-8DF1-4163-9498-C00CB589CC60Q34510564-BEDBA444-5518-4106-804F-94394A631999Q35169054-9DAA630D-8A20-4C14-8B93-735BCFE69F4EQ35191417-DFB960BD-1F45-4D88-A1D4-B47AAA4ED569Q35192492-D9AAE875-73FF-4592-8FB9-6CB5B347143EQ35587135-5E3E85EF-458C-4022-91EF-A67607E392F3Q35842532-F400C99E-2338-4E9B-9E12-CC7C96C19680Q36870340-C2DD2890-D3CA-453E-BB08-FF7DA3BF8223Q37190750-D385489A-9623-4E28-99EC-9E674D40DEADQ37461413-19D3DDEF-20DD-4E14-90CE-D3A336926A95Q37544854-71DDBAE9-D742-42B9-B9A6-0532E10C0740Q38232037-26B0DA35-E130-42E2-B97B-4C181A9575C1Q38899451-6D350DCB-6EF6-430D-90C3-C0D413E2AAC8Q40335746-A4756FE1-C833-4D23-BEA2-42D632C33EC5Q41080451-50370225-DFCD-4A34-9352-ACEC5F08E7CBQ41092910-654BFA30-A105-4B6A-A6B3-74FDA79B58F8Q41269099-9778E956-3FF4-443B-B846-8334260267E6Q41783624-1C5BBC4D-A797-4919-9EF5-9027D141C203Q41789307-F3244415-057A-499A-A87A-732E46446DC2Q42111061-190452F2-EDC5-4C47-8FD1-FE0F4F809D17Q44419760-6E34940F-E85C-478F-852B-FFA3920304B0Q44814819-4532483C-695D-451E-B7BB-535C1141E184Q44958662-7BD1EDE4-E2E1-41FD-B64B-5F9A2A567CB4
P2860
PBP 2a mutations producing very-high-level resistance to beta-lactams.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
PBP 2a mutations producing very-high-level resistance to beta-lactams.
@ast
PBP 2a mutations producing very-high-level resistance to beta-lactams.
@en
type
label
PBP 2a mutations producing very-high-level resistance to beta-lactams.
@ast
PBP 2a mutations producing very-high-level resistance to beta-lactams.
@en
prefLabel
PBP 2a mutations producing very-high-level resistance to beta-lactams.
@ast
PBP 2a mutations producing very-high-level resistance to beta-lactams.
@en
P2093
P2860
P1476
PBP 2a mutations producing very-high-level resistance to beta-lactams.
@en
P2093
Henry F Chambers
Hong-Zhong Zhang
Yuki Katayama
P2860
P304
P356
10.1128/AAC.48.2.453-459.2004
P407
P577
2004-02-01T00:00:00Z